Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_assertion description "[We have demonstrated that treatment with calcineurin inhibitors (CNIs) can induce the activation of proto-oncogenic Ras, and may promote a rapid progression of human renal cancer through the overexpression of vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_assertion evidence source_evidence_literature NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_assertion SIO_000772 21886838 NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_assertion wasDerivedFrom befree-20140225 NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_assertion wasGeneratedBy ECO_0000203 NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP814333.RAOz-ZalnDh-LfbmNHvQp2gekLxyLvj-aF-iAWhKBecGM130_provenance.